DE1667888C3 - Langwirkende geformte pharmazeutische Zubereitungen - Google Patents

Langwirkende geformte pharmazeutische Zubereitungen

Info

Publication number
DE1667888C3
DE1667888C3 DE1968L0058659 DEL0058659A DE1667888C3 DE 1667888 C3 DE1667888 C3 DE 1667888C3 DE 1968L0058659 DE1968L0058659 DE 1968L0058659 DE L0058659 A DEL0058659 A DE L0058659A DE 1667888 C3 DE1667888 C3 DE 1667888C3
Authority
DE
Germany
Prior art keywords
active ingredient
cellulose
release
tablets
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1968L0058659
Other languages
German (de)
English (en)
Other versions
DE1667888B2 (de
DE1667888A1 (de
Inventor
Hans Mamaroneck Lowey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE1667888A1 publication Critical patent/DE1667888A1/de
Publication of DE1667888B2 publication Critical patent/DE1667888B2/de
Application granted granted Critical
Publication of DE1667888C3 publication Critical patent/DE1667888C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE1968L0058659 1967-02-24 1968-03-23 Langwirkende geformte pharmazeutische Zubereitungen Expired DE1667888C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB900467A GB1171691A (en) 1967-02-24 1967-02-24 Lond-Acting Oral Carrier

Publications (3)

Publication Number Publication Date
DE1667888A1 DE1667888A1 (de) 1971-07-22
DE1667888B2 DE1667888B2 (de) 1977-11-10
DE1667888C3 true DE1667888C3 (de) 1978-07-13

Family

ID=9863505

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1968L0058659 Expired DE1667888C3 (de) 1967-02-24 1968-03-23 Langwirkende geformte pharmazeutische Zubereitungen

Country Status (5)

Country Link
BE (1) BE711241A (US20080293856A1-20081127-C00150.png)
DE (1) DE1667888C3 (US20080293856A1-20081127-C00150.png)
DK (1) DK122997B (US20080293856A1-20081127-C00150.png)
GB (1) GB1171691A (US20080293856A1-20081127-C00150.png)
NL (1) NL142073B (US20080293856A1-20081127-C00150.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
DE2530563C2 (de) * 1975-07-09 1986-07-24 Bayer Ag, 5090 Leverkusen Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
GB1593261A (en) 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4357469A (en) 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4885173A (en) 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
FR2621483B1 (fr) * 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
GB8802391D0 (en) * 1988-02-03 1988-03-02 Ddsa Pharmaceuticals Ltd Medicinal formulations
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity

Also Published As

Publication number Publication date
DE1667888B2 (de) 1977-11-10
NL142073B (nl) 1974-05-15
DE1667888A1 (de) 1971-07-22
DK122997B (da) 1972-05-08
BE711241A (US20080293856A1-20081127-C00150.png) 1968-07-01
GB1171691A (en) 1969-11-26
NL6802594A (US20080293856A1-20081127-C00150.png) 1968-08-26

Similar Documents

Publication Publication Date Title
DE1667888C3 (de) Langwirkende geformte pharmazeutische Zubereitungen
DE3309516C2 (US20080293856A1-20081127-C00150.png)
DE69821553T2 (de) Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat
DE3875705T2 (de) Carbidopa-levodopa-zusammensetzung mit gesteuerter freigabe.
DE3246492C2 (de) Verfahren zur Herstellung therapeutischer Präparate auf der Basis von Hydroxypropylmethylzellulose mit verlängertem Freisetzungsverlauf
DE3443587C2 (de) Pharmazeutischer Trägerstoff, und diesen enthaltendes Langzeitpräparat
EP1067905B1 (de) Brauseformulierungen
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE60133538T2 (de) Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung
DE1492107C3 (de) Verfahren zur Herstellung einer Acetylsalicylsauretablette
DE3689983T2 (de) Arzneimittel mit langsamer Wirkstofffreisetzung.
DE2332484C2 (de) Arzneimittel mit verzögerter Wirkstoffabgabe
CH644759A5 (de) Pharmazeutisches praeparat mit langsamer wirkstofffreisetzung und verfahren zu dessen herstellung.
DE2323686A1 (de) Arzneimittelzubereitungsform mit langzeitwirkung und verfahren zu ihrer herstellung
DD285720A5 (de) Verfahren zur herstellung einer saeurebindenden, aufschaeumenden zubereitung
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE60020501T3 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
CH665124A5 (de) Verfahren zur herstellung von tabletten mit regulierter wirkstoffabgabe.
EP1509207B1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE69635298T2 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
DE2718260C2 (de) Verfahren zur Herstellung einer therapeutischen Zusammensetzung
DE1935879C3 (de) Verfahren zur Herstellung eines pharmazeutischen Lithium-Präparates

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
EGA New person/name/address of the applicant